Marcus Schmidt

Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer

K. Milde-Langosch, R. Wirtz, F. Jänicke, 2010, British Journal of Cancer.

Role of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) for prognosis in endometrial cancer.

D. Hasenclever, E. Steiner, A. Puhl, 2008, Gynecologic oncology.